Distinct functions of activated protein C differentially attenuate acute kidney injury

Journal of the American Society of Nephrology

Volumn 20, Issue 2, 2009, Pages 267-277

  Gupta, Akanksha ^a   Gerlitz, Bruce ^a   Richardson, Mark A ^a   Bull, Christopher ^a   Berg, David T ^a   Syed, Samreen ^a   Galbreath, Elizabeth J ^a   Swanson, Barbara A ^b   Jones, Bryan E ^a   Grinnell, Brian W ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Applied Molecular Evolution   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADRENOMEDULLIN; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROTEINASE ACTIVATED RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD PRESSURE; CELL INFILTRATION; CELL PROTECTION; HEMODYNAMICS; HYPOTENSION; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION;

EID: 59949102639     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008030294     Document Type: Article

References (60)

1. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004
2. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S: Renal blood flow in sepsis. Crit Care 9: R363-F374, 2005
3. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
4. Ronco C, Kellum JA, Bellomo R, House AA: Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 3: 531-544, 2008
5. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome(SIRS). A prospective study. JAMA 273: 117-123, 1995
6. Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 112: 460-467, 2003
7. Vincent J, Bota D, De Backer D: Epidemiology and outcome in renal failure. Int J Artif Organs 27: 1013-1018, 2004
8. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004
9. Heuer JG, Sharma GR, Gerlitz B, Zhang T, Bailey DL, Ding C, Berg DT, Perkins D, Stephens EJ, Holmes KC, Grubbs RL, Fynboe KA, Chen YF, Grinnell B, Jakubowski JA: Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med 32: 1570-1578, 2004
10. Macias WL, Nelson DR: Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 32: S223-S228, 2004
11. Gupta A, Berg DT, Gerlitz B, Sharma GR, Syed S, Richardson MA, Sandusky G, Heuer JG, Galbreath EJ, Grinnell BW: Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol 18:860-867, 2007
12. Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW:Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol 293: F245-F254, 2007
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher, CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699 -709, 2001
14. Mizutani A, Okajima K, Uchiba M, Noguchi T: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95: 3781-3787, 2000
15. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272: L197-L202, 1997
16. Esmon CT: The protein C pathway. Chest 124: 26S-32S, 2003
17. Mosnier LO, Yang XV, Griffin JH: Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity and preservation of TAFI-dependent cytoprotective functions. J Biol Chem 282: 33022-33033, 2007
18. Mosnier LO, Griffin JH: Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J 373:65-70, 2003
19. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW: Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276: 11199-11203, 2001
20. Mosnier LO, Zlokovic BV, Griffin JH: The cytoprotective protein C pathway. Blood 109: 3161-3172, 2007
21. O'Brien L, Richardson M, Mehrbod S, Berg D, Gerlitz B, Gupta A, Grinnell B: Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand byan EPCR-independent mechanism involving Egr-1/Erk-1/2 activation. Arterioscler Thromb Vasc Biol 27: 2634-2641, 2007
22. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG: Activated protein C mediates novel lung endothelial barrier enhancement: Role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280: 17286-17293, 2005
23. Feistritzer C, Riewald M: Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105: 3178-3184, 2005
24. Choi G, Hofstra JJ, Roelofs JJ, Florquin S, Bresser P, Levi M, van der Poll T, Schultz MJ: Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats. Crit Care Med 35: 1362-1368, 2007
25. Grinnell B, Joyce DE: Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis. Crit Care Med 29: S53-S61, 2001
26. Dahlback B: Blood coagulation. Lancet 355: 1627-1632, 2000
27. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV: Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9: 338 -342, 2003
28. Kerschen E, Fernandez J, Cooley B, Yang X, Sood R, Mosnier L, Castellino F, Mackman N, Griffin J, Weiler H: Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med 204: 2439 -2448, 2007
29. Esmon CT: Is APC activation of endothelial cell PAR1 important in severe sepsis?: No. J Thromb Haemost 3: 1910-1911, 2005
30. Gupta A, Berg DT, Gerlitz B, Richardson MA, Galbreath E, Syed S, Sharma AC, Lowry SF, Grinnell BW: Activated protein C suppresses adrenomedullin and ameliorates lipopolysaccharide-induced hypotension. Shock 28: 468 -476, 2007
31. Glasscock NL, Gerlitz B, Cooper ST, Grinnell BW, Church FC: Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin. Biochim Biophys Acta 1647: 106-117, 2003
32. Mosnier LO, Gale AJ, Yegneswaran S, Griffin JH: Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood 104: 1740-1744, 2004
33. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K: Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104: 1171-1175, 2001
34. Ruf W: Is APC activation of endothelial cell PAR1 important in severe sepsis?: Yes. J Thromb Haemost 3: 1912-1914, 2005
35. Naldini A, CarneyD, Bocci V, Klimpel K, Asuncion M, Soares L, Klimpel G: Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 147: 367-377, 1993
36. Shin H, Kitajima I, Nakajima T, Shao Q, Tokioka T, Takasaki I, Hanyu N, Kubo T, Maruyama I: Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts. Ann Rheum Dis 58:55-60, 1999
37. Fan Y, Zhang W, Mulholland M: Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. J Surg Res 129: 196-201, 2005
38. Martinez-Sales V, Vila V, Ferrando M, Reganon E: Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells. Endothelium 14: 233-238,2007
39. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 365: 417-430, 2005
40. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16: 3046 -3052, 2005
41. Chin A, Vergnolle N, MacNaughton W, Wallace J, Hollenberg M, Buret A: Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci U SA100: 11104 -11109, 2003
42. Lopez J, Salido G, Góomez-Arteta E, Rosado J, Pariente J: Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 5: 1283-1291, 2007
43. Suzuki T, Moraes T, Vachon E, Ginzberg H, Huang T, Matthay M, Hollenberg M, Marshall J, McCulloch C, Abreu M, Chow C, Downey, G: Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 33:231-247, 2005
44. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882, 2002
45. Dear JW, Yasuda H, Hu X, Hieny S, Yuen PS, Hewitt SM, Sher A, Star RA: Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: Acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int 69: 832-836, 2006
46. Molitoris BA, Sutton TA: Endothelial injury and dysfunction: Role in the extension phase of acute renal failure. Kidney Int 66: 496-499, 2004
47. Weber JR, Angstwurm K, Rosenkranz T, Lindauer U, Freyer D, Burger W, Busch C, Einhaupl KM, Dirnagl U: Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis. J Cereb Blood Flow Metab 17:1221-1229, 1997
48. Taylor FB Jr, Chang AC, Peer GT, Mather T, Blick K, Catlett R, Lockhart MS, Esmon CT: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78: 364-368, 1991
49. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA: Efficacy and safety of tifacogin(recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 290: 238 -247, 2003
50. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial. JAMA 286: 1869-1878, 2001
51. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
52. Gerlitz B, Hassell T, Vlahos C, Parkinson JF, Bang NU, Grinnell BW:Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: Potential regulation of functionality by glycosyltransferase competition for serine 474. Biochem J 295: 131-140, 1993
53. Fukudome K, Kurosawa S, Stearns-Kurosawa D, He X, Rezaie A, Esmon C: The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 271: 17491-17498, 1996
54. Sandusky G, Berg DT, Richardson MA, Myers L, Grinnell BW: Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads. J Biol Chem 277: 49815-49819, 2002
55. Bentley MD, Lerman LO, Hoffman EA, Fiksen-Olsen MJ, Ritman EL, Romero JC: Measurement of renal perfusion and blood flow with fast computed tomography. Circ Res 74: 945-951, 1994
56. Hillman BJ, Lee SM, Tracey P, Swindell W, Long DM: CT determination of renal and hepatic microvascular volumes in experimental acute renal failure. Invest Radiol 17: 41-45, 1982
57. Kan Z, Phongkitkarun S, Kobayashi S, Tang Y, Ellis LM, Lee TY, Charnsangavej C: Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology 237: 151-158, 2005
58. Young LS, Regan MC, Barry MK, Geraghty JG, Fitzpatrick JM: Methods of renal blood flow measurement. Urol Res 24: 149 -160, 1996
59. Sutton T, Fisher C, Molitoris B: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002
60. Friedewald J, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491, 2004